Zheng, C., Lin, M., Chen, Y., Xu, H., Yan, L., & Dai, H. (2021). Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: A meta‐analysis of randomized controlled trials. Cardiovasc Diabetol.

Zheng, Caiyun, Meimei Lin, Yan Chen, Haiting Xu, Lingqun Yan, and Hengfen Dai. "Effects of Sodium‐glucose Cotransporter Type 2 Inhibitors On Cardiovascular, Renal, and Safety Outcomes in Patients With Cardiovascular Disease: A Meta‐analysis of Randomized Controlled Trials." Cardiovasc Diabetol 2021.

Zheng, Caiyun, et al. "Effects of Sodium‐glucose Cotransporter Type 2 Inhibitors On Cardiovascular, Renal, and Safety Outcomes in Patients With Cardiovascular Disease: A Meta‐analysis of Randomized Controlled Trials." Cardiovasc Diabetol 2021.